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Forward
The proposal of a major review of the health services available to those people infected with
Hepatitis C through the administration of blood and blood products was first suggested by
Positive Action. Services had been evolving since 1994 and it was considered timely to examine
the current provision and to plan for the future service needs.
The Consultative Council on Hepatitis C was please to be asked by the then Minister for Health
and Children, Mr. Brian Cowen, T.D., to direct, co-ordinate and oversee such a review. The term
of office of the first Consultative Council is drawing to a close, and the completion of this review
counts as one of the main achievements of our three-year term of office.
The four support groups, Positive Action, Transfusion Positive, the Irish Haemophilia Society
and the Irish Kidney Association, all of which are represented on the Consultative Council, are
to be commended for their invaluable input, particularly in encouraging their members to
participate in the review. The report will assist health service providers, the Department of
Health and Children and the support groups to continue their working relationship to ensure
that the future service needs of this Hepatitis C group are met.
The individual representative groups will play a significant part in ensuring that where
necessary, the services will be customised to suit the particular clinical, psychological and social
needs of their members. The Council recognises that this review is not an end in itself but part
of an on-going process which will continue to examine and evaluate the available services.
On behalf of the Council, I would like to thank the authors of the report, Professor Hannah
McGee and Dr. Anne Hickey and their research team, Ms Mary Smith and Ms Molly Bryne. I
also want to thank all the members of the Consultative Council who gave the benefit of their
expertise throughout the conduct of the review. I particularly want to thank the chair of the
review sub-committee, Dr Vivian O’Gorman, and the members of the committee.
On behalf of the Council, I am please to present this report to the Minister for Health and
Children, Mr Michéal Martin, T.D. I believe that the incoming Council will have an important
role in the implementation process and will provide support and guidance as required.
_________________________________
Leonie Lunny
Chair, Consultative Council on Hepatitis C
March 2000
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Preface
This review was commissioned by the Consultative Council on Hepatitis C of the Department
of Health and Children. The Health Services Research Centre (HSRC) at the Department of
Psychology, Royal College of Surgeons in Ireland conducted the review. The HSRC is a
multidisciplinary centre established in 1997 to promote quality health care delivery in Ireland.
The review was directed by Professor Hannah McGee and Dr Anne Hickey. Professor McGee is
a health psychologist and HSRC director. Dr Hickey is a health psychologist and grant-holder
on another hepatitis C research project since 1997. Two researchers complete the research team:
Ms Mary Smith, research nurse and project co-ordinator, and Ms Molly Byrne, health
psychologist. The review was completed between July 1998 and June 1999.
The completion of the review depended on the co-operation of many individuals and
organisations. Those consulted in their working roles for the review are acknowledged by name
in Appendix 1 and others are listed on the following page. 
We have produced the review on the basis of the information provided to us and have
endeavoured to represent both the broad view on issues and the range of views where there is a
discrepancy of opinion. The account and the inferences drawn are those of the Health Services
Research Centre. 
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Executive summary
Background 
 Following the discovery in 1994 that anti-D immunoglobulin manufactured by the Irish
Blood Transfusion Services Board (BTSB) was infected with hepatitis C, testing, identified
approximately 1,600 people infected with hepatitis C though administration within the
State of blood or blood products.
 Specialist hepatology services were established in six designated hospitals nationwide to
provide services for this group. A seventh centre has since been established.
 The Health (Amendment) Act, 1996, provided statutory entitlements to a range of primary
health care services to persons with hepatitis C following receipt of blood or blood products.
 In 1996, a Consultative Council on Hepatitis C was established by the Minister for Health
to advise and make recommendations to the Minister on all aspects of care of this hepatitis
C group. It commissioned this review.
 The review documents use of, and views on, service quality and future service needs from
hospital chart reviews and from individual interviews with infected persons, relevant
professionals and administrators from hospitals, health boards, disease-specific support
organisations, and relevant national agencies.
Review methodology 
 Medical chart review: Twenty-five percent of randomly selected hospital charts were
surveyed for service use in each of the seven centres nationally (N=388; 99% of charts were
available for review).
 Interviews with hepatitis C-infected individuals: Focus group sessions with representatives
from four patient representative organisations informed development of a structured
interview schedule. A random sample of patients was invited from each centre to provide a
nationally representative sample of each infection group (that is, anti-D, haemophilia, renal,
transfusion, and ‘recall’) (N=132; 37% response).
 GP survey: Randomly selected GPs who had billed for services under the Health
(Amendment) Act in the previous year were surveyed by post regarding care provided for
patients with hepatitis C (N=150; 57% response).
 Health services personnel interviews: Sixty-four individuals were consulted or interviewed
as part of this review including staff from hospitals (medical and administrative staff), health
boards, the Irish College of General Practitioners, support groups, the BTSB, the
Department of Health and Children, and the Health Research Board. Private and health
board employed counsellors were also interviewed.
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Secondary care 
Liver biopsy
 Sixty-three percent had undergone at least one biopsy; most (77%) were satisfied with the
overall experience. 
 Medical consultants provide qualitative rather than numerical test results. Most patients
(77%) reported satisfaction with biopsy result communication while one support
organisation strongly argued for the value of providing numerical test results.
Interferon
 Eighteen percent had undergone interferon therapy. Most (77%) were satisfied with medical
assistance but fewer (40%) with general counselling and support while on interferon.
 Interviews with secondary care providers reflected a general view that interferon services are
operating quite successfully. This discrepancy of opinion (between patients and support
groups on one side and secondary care providers on the other) is cause for concern. 
Recommendation 1: That a committee be established to agree treatment
protocols (including liver biopsy procedures and scoring, and administration of
anti-viral therapy) for this particular group. The committee should comprise the
medical consultants with primary responsibility for this group of patients and be
chaired on a rotating basis.
 The non-hepatology service to which the highest number of referrals was made was
rheumatology (9%), followed by gynaecology and ophthalmology (5% each). Staff
expressed concern over the availability of physiotherapy services. Problems were also
identified in implementation of the two-week referral system.
Recommendation 2: That the system whereby patients are referred by their
consultant hepatologist to another specialty be regularised to facilitate
Hepatology Unit staff in making priority referrals in accordance with the ‘two-
week’ rule. A comprehensive system for physiotherapy should be established to
ensure that it is available to all who require it.
 There was seen to be confusion regarding regulations concerning management of the person
with hepatitis C following death, with the potential to cause considerable anxiety and
possible inappropriate and insensitive management of individuals concerned and for their
families. 
Recommendation 3: That guidelines be developed for the management of
death, including funeral arrangements, so that the necessary safe practices are
understood and accepted by all concerned.
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Primary care services 
 These services are coordinated by a liaison officer in each of the eight health boards to
ensure efficient delivery of primary care services. This role is seen to operate very effectively.
The continuing contribution of this group was seen as important.
Recommendation 4: That health board liaison officers meet on a regular basis
to ensure uniformity and continuity in the provision of primary health care
services.
Counselling and home help services
 Half (51%) of the group had availed of counselling at some time since diagnosis with three-
quarters of this group intending to use services again. Satisfaction with services was high
(82% rating or ‘good’ or higher) despite significant initial reluctance by 57% of users.
Recommendation 5: That health board liaison officers ensure choice of
counsellors and counselling locations in all health board areas.
 A quarter (24%) of the group currently use home support services, averaging about 10
hours service weekly; current satisfaction with service provision for users was high (88%).
 Sixty-two percent of those availing of home support services have nominated their own
home support, an option unique to this patient group. Use of home support raises challenges
for patients regarding confidentiality and for health boards regarding training and health
and safety.
Recommendation 6: That a general training programme for all home support
providers be available. This programme must have as a basis an agreed strategy
regarding the balance to be achieved between duty of care to the provider and
the right to confidentiality of health information of the recipient.
 Difficulties in relation to differential rates of pay between health boards and ongoing
recruitment of providers of home support services were identified.
Recommendation 7: That the issues surrounding the difficulty in recruitment of
home support providers, including remuneration issues, be reviewed to ensure
availability of the service to all who require it.
General practice services
 Almost all patients (95%) have a GP whom they regularly attend. A significant minority
(19%) had changed GP since hepatitis C diagnosis (19% also reporting having difficulty
with a GP since diagnosis); satisfaction with current GP services was very high (89%) and
similar across groups with different routes of infection. (This level is somewhat higher than
found in a recent large general practice survey (81%) across two health boards.)
Other primary care services
 Difficulties were noted by interviewed patients with dental service provision concerning
eligibility and infectivity; 75% of users were satisfied with services. 
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 Pharmacy services were seen as generally of high quality including attending to
confidentiality; 83% of users reported satisfaction with services. 
Recommendation 8: That staff in all primary care disciplines dealing with this
patient group (including general practitioners, dentists, and pharmacists) be
adequately informed about both the actual risk of transmission of hepatitis C
and the guidelines on universal precautions against transmission of infection;
this is to ensure that such patients are treated in a sensitive manner.
Complementary therapy
 A quarter (24%) of the interviewed group had tried complementary therapies for hepatitis
C; over half (62%) of their consultants were aware of their use of such therapies.
 Medical consultants were neutral regarding use of therapies excepting those involving
needles or herbal remedies likely to spread infection or damage an already weakened liver
respectively. Most neither objected to nor referred for other therapies.
 Resources for complementary therapies differed across health boards and hospitals.
Recommendation 9: That the role of complementary or alternative therapies in
the management of hepatitis C be reviewed as part of a wider framework of
evaluation of the use of such therapies in the Irish health system.
Research on hepatitis C in Ireland
 There was consensus that a unique opportunity exists for internationally significant research
which can inform both treatment and understanding of the nature of the hepatitis C process.
 There was also agreement that hepatitis C research in Ireland would be greatly advanced by
the availability of a national independent database of those affected by the virus. 
Recommendation 10: That a national database be established for research
purposes; this to be located at an independent coordinating agency and run in
association with relevant groupings.
Hepatitis C: current status and service needs in the future
Current clinical status 
 Thirty-nine percent of patients in the chart review group were PCR negative. Of PCR
positive patients, classification of disease severity was possible for 70%: 20% of these had
chronic hepatitis C with normal ALT; 50% had chronic mild disease and 30% had chronic
moderate/severe disease.
 It is likely that the longer-term prognosis in these patients, even those classified with
moderate/severe disease, is good, with only a small number showing evidence of serious liver
disease.
Current psychological well-being
 High levels of both depression and anxiety were identified by standardised assessment, with
26% and 35% of the group showing clinical levels of depression and anxiety respectively.
These levels did not vary significantly according to route of infection. 
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 Those who had attended the Compensation Tribunal had a more serious depression profile
than those who had not (with 32% versus 7% in the clinical depression score range). A
trend was evident for anxiety scores, where scores for both groups were uniformly high
(22% and 39%).
Disclosure, stigma, and confidentiality
 A third of those interviewed reported feeling stigmatised by their diagnosis of hepatitis C. 
 Patients were generally satisfied with confidentiality of personal information and identity in
a range of health services (86% satisfied/very satisfied). 
Recall patients
 Twenty-three ‘recall’ patients, that is those initially tested negative for hepatitis C and
recently asked to return for further testing, were included in this study; most (81%) reported
alarm on being asked to retest. 
 Many were unclear about the reasons for retesting, over half stating that they did not have
adequate understanding of why they were being retested. Even though all had tested
negative in the second series of tests, 48% still remained fearful about diagnosis of hepatitis
C. 
 General health and psychological well-being for this group did not differ significantly from
other groups interviewed. 
Future service needs and concerns 
 The major concerns for all groups were for increased understanding of the course and
management of hepatitis C and for guarantees regarding long-term commitment for the
funding necessary to provide optimum care.
Recommendation 11: That assurances be given that adequate funding and
resources will continue to be provided to ensure a quality health care service for
this patient group.
General conclusions and recommendations 
 The constituents necessary for effective service delivery including staff, facilities, protected
funding, and a perceived willingness of professionals, patients, and representative
organisations, appear to be in place for those infected by hepatitis C through State-provided
blood products. Implementation of the recommendations of this Review should serve to
promote a coordinated, comprehensive service which will optimize patient care into the
future.
Recommendation 12: That progress on the recommendations of this Review be
monitored on an annual basis for three years with a report summarising
progress to be completed at the end of this period. Progress to be monitored by
a sub-committee of the Consultative Council on Hepatitis C.
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REVIEW RECOMMENDATIONS
 That a committee be established to agree treatment protocols (including liver biopsy
procedures and scoring, and administration of anti-viral therapy) for this particular group.
The committee should comprise the medical consultants with primary responsibility for this
group of patients and be chaired on a rotating basis.
 That the system whereby patients are referred by their consultant hepatologist to another
specialty be regularised to facilitate Hepatology Unit staff in making priority referrals in
accordance with the ‘two-week’ rule. A comprehensive referral system for physiotherapy
should be established to ensure that it is available to all who require it.
 That guidelines be developed for the management of death, including funeral arrangements,
so that the necessary safe practices are understood and accepted by all concerned.
 That health board liaison officers meet on a regular basis to ensure uniformity and
continuity in the provision of primary health care services.
 That health board liaison officers ensure choice of counsellors and counselling locations in
all health board areas.
 That a general training programme for all home support providers be available. This
programme must have as a basis an agreed strategy regarding the balance to be achieved
between duty of care to the provider and the right to confidentiality of health information
of the recipient.
 That the issues surrounding the difficulty in recruitment of home support providers,
including remuneration issues, be reviewed to ensure availability of the service to all who
require it.
 That staff in all primary care disciplines dealing with this patient group (including general
practitioners, dentists, and pharmacists) be adequately informed about both the actual risk of
transmission of hepatitis C and the guidelines on universal precautions against transmission
of infection; this is to ensure that such patients are treated in a sensitive manner.
 That the role of complementary or alternative therapies in the management of hepatitis C
be reviewed as part of a wider framework of evaluation of the use of such therapies in the
Irish health system.
 That a national database be established for research purposes; this to be located at an
independent coordinating agency and run in association with relevant groupings.
 That assurances be given that adequate funding and resources will continue to be provided
to ensure a quality health care service for this patient group.
 That progress on the recommendations of this Review be monitored on an annual basis for
three years with a report summarising progress to be completed at the end of this period.
Progress to be monitored by a sub-committee of the Consultative Council on Hepatitis C.
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Chapter 1
INTRODUCTION AND TERMS OF REFERENCE
BACKGROUND
Hepatitis C is a relatively common blood-borne infectious disease. It has been estimated that 3%
of the world’s population is infected. Hepatitis C accounts for about 20% of cases of acute
hepatitis and 70% of cases of chronic hepatitis. Its importance is that it is a major cause of
cirrhosis and hepatocellular cancer1. End-stage liver disease secondary to hepatitis C virus
infection is main reason for liver transplantation. 
Following the discovery in February 1994 that anti-D immunoglobulin manufactured by the
Irish Blood Transfusion Service Board was infected with hepatitis C, a number of screening
programmes were put in place to identify those persons who had been infected, either directly
or indirectly. It is estimated that about 1,600 persons have been infected with hepatitis C
through the administration of blood and blood products in the Republic of Ireland.
Acute hospital services for persons diagnosed positive for hepatitis C were put in place in 1994
in specialist hepatology (liver) units at six designated hospitals: Beaumont Hospital, the Mater
Hospital, St Vincent’s Hospital, Elm Park, and St James’s Hospital in Dublin, Cork University
Hospital, and University College Hospital in Galway. More recently, St Luke’s Hospital in
Kilkenny has been included in the list of hospitals funded to provide specialist hepatology
services. These services, provided under the Health Act (1970), are free of charge and include
access to both in-patient and out-patient treatment as required.
On 23 September 1996, the Health (Amendment) Act (1996) came into effect. This legislation
provided statutory entitlement to a range of primary health care services, free of charge, to
persons who have contracted hepatitis C from the receipt of a blood product or blood
transfusion. The services provided include general practitioner services, medicines, home nursing
services, home support services, dental, opthalmic, and aural services, as well as counselling
services. At the request of the then Minister for Health, each health board appointed a liaison
officer to ensure the efficient delivery of services under the Act, and to serve as a contact point
for individuals and various interest groups whose members can avail of services under the Act. A
Health Care Package for secondary services was also agreed between Positive Action and the
Department of Health and Children in 1995. This covered entitlements to hospital treatments
and sought to ensure sufficient funding, staffing, and facilities to provide high quality and
appropriate secondary care services to those requiring them as a consequence of hepatitis C.
______________________________
1 Marcellin P. The clinical spectrum of the disease. International consensus conference on hepatitis C (1) 1999; 1: 1-6. 
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CONSULTATIVE COUNCIL ON HEPATITIS C
The Consultative Council on Hepatitis C was established by the Minister for Health in
November 1996 to advise and make recommendations to the Minister on all aspects of hepatitis
C, including the organisation, delivery, and on-going review of services for persons with
hepatitis C. The Council may advise and make recommendations on its own initiative, or at the
request of the Minister.
REVIEW OF THE HEALTH SERVICES FOR PERSONS WITH HEPATITIS C
In 1998, the Council was requested by the Minister to oversee a major review of the health
services - both secondary and primary - available to persons who contracted hepatitis C through
the administration within the State of blood and blood products. The Health Services Research
Centre, Department of Psychology, Royal College of Surgeons in Ireland was commissioned to
conduct the review on the Council’s behalf.
Review framework
The Council was concerned to ensure that the health services respond efficiently and effectively
to the changing needs of persons with hepatitis C. In this regard, the current review involved:
 analysis of the services currently available, including their delivery;
 recommendations on how these services could be improved (with particular regard to the
need for consistency of approach across the various hospitals and health boards); and
 recommendations on services which should be provided to persons with hepatitis C. 
The review involved consulting with a wide range of groups, including persons iatrogenically2
infected with hepatitis C, support groups, primary and secondary care providers, and State
institutions. It assessed the structures, processes, and outcomes of current health services as
perceived by these groups and developed recommendations, where appropriate, aimed at
providing an effective and efficient service to meet evolving needs of persons with hepatitis C.
Information was collected using a variety of methodologies in the following sequence: hospital
chart review; focus groups of persons infected by different routes of infection; interviews with
disease-specific support organisations; an interview-based survey of specialist unit registered
patients3; interviews and postal surveys with health professionals; and interviews with national
policy organisations. 
The review aimed to provide a first national profile of:
 the population base and health service management of persons who contracted hepatitis C
through State-provided blood products;
 the view of interested parties, as specified by the Consultative Council on Hepatitis C, on
current service adequacy and future service needs. 
______________________________
2 ‘iatrogenic’: where medical problems are induced by medical treatment of another condition. The term ‘iatrogenic’ here
distinguishes those infected through State-provided blood products from persons infected through other means such as injecting
illicit drugs.
3 the term ‘person with hepatitis c’ and ‘patient’ are used interchangeably. As much of the discussion is about individuals’ use of and
views on services in the medical or health setting, the term ‘patient’ was considered appropriate.
two
Table 1.1 outlines those consulted for the review. 
Appendix 1 acknowledges the personnel consulted.
Table 1.1: Consultation process for hepatitis C services review: those
interviewed/consulted for review
Location/group Personnel consulted
Hospitals
Staff of specialist units in the seven hospitals: ❖ Relevant consultants
Beaumont Hospital, Dublin ❖ Nurses or nurse counsellors
Cork University Hospital ❖ Secretaries
Mater Hospital, Dublin
St James’s Hospital, Dublin
St Luke’s Hospital, Kilkenny
St Vincent’s Hospital, Dublin
University College Hospital, Galway
Health boards ❖ Hepatitis C liaison officers
Primary care ❖ Irish College of General Practitioners
❖ 150 randomly selected general practitioners 
who provided services under the Health 
(Amendment) Act, July 1997-June 1998 
(N=86; 57% response)4
❖ Counsellors
Support groups
For those infected with hepatitis C ❖ Irish Haemophilia Society
through State-provided blood products – ❖ Irish Kidney Association
executive committees or representatives ❖ Positive Action
of same ❖ Transfusion Positive
Persons with hepatitis C ❖ Four focus groups of persons identified by 
national support organisations (N=28)
❖ 373 persons invited to participate 
in interview (37% accepted)5; 132 persons 
completed interviews across seven hospitals6
❖ Review of 388 relevant hospital medical charts 
(99% of overall; 25% national review achieved)7
Relevant national agencies ❖ Blood Transfusion Service Board
❖ Expert Committee on Hepatitis C, 
Department of Health and Children
❖ Health Research Board
Others ❖ Pathologist – specialist in hepatitis C
❖ Epidemiological and general practice advice
From these consultations, recommendations were developed to promote a coordinated, comprehensive,
and accountable service ensuring the best achievable service for this unique group within the Irish
health system in the coming years.
______________________________
4 150 GPs contact by postal questionnaire
5 interview acceptance rate: letter followed by researcher telephone contact (five hospitals) - 61%; letter with patient returning envelope to 
indicate consent (two hospitals) - 25% 
6 small proportion agreed to telephone rather than face-to-face interview because of distance to travel to centre.
7 hospital-based chart review
three
four
Chapter 2
REVIEW METHODOLOGY
The methodology to address the areas identified in the Review Framework can be described
under four main headings:
 information relating directly to the patient population, in terms of current medical status,
levels of service use, and patient views on services; 
 information from the secondary care (hospital) units, including interviews with unit staff; 
 information from primary care services, including interviews with health board personnel;
and
 information from specific individuals representing State institutions that have direct
involvement with the hepatitis C issue.
PATIENT INFORMATION
Information on patients focussed both on their clinical status (from a review of patients’ hospital
charts) and on patient experiences and views on services (from interviews with patients). Chart
review took place in each of the seven hepatology units. Patients invited for interview were also
identified through these units. Ethical approval for the study was obtained from the Research
Ethics Committee of each hospital.
Hospital chart review
Aim
To obtain a detailed profile of the current clinical status and health service use of the hepatitis
C patient cohort.
Procedure
Hospital chart review: Information was anonymously recorded on demographic profile, PCR8
status, date(s) of liver biopsy(s), liver biopsy results, details of number of blood test and blood
test results, attendance at other hospital specialties, and details of hospital admissions. A review
of 25% of relevant hospital charts in each of the seven centres was conducted. Charts were
randomly selected from clinic listings.
Patient interviews: Patient lists in the hepatology units were used to identify those invited to take
part in interviews. The selection criterion used was route of infection. This was to allow for
adequate representation of the views of the different groupings within the hepatitis C cohort.
______________________________
8 PCR: the Polymerase Chain Reaction (PCR) test is used to find out if hepatitis C virus is in blood. It checks for generic material of 
the virus. A positive PCR result means that the hepatitis C virus is present in blood while a negative test means the virus is not 
present (although, antibodies, identified by other tests, may be present).
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The aim was to interview a total of 150 individuals; 30 randomly selected people who had
contracted hepatitis C through each of the following routes:
 anti-D administration (‘anti-D’)
 anti-D administration – those recalled following initially negative results (‘recall’)9
 blood transfusion for reasons other than above (‘transfusion’)
 treatment for renal disease (‘renal’)
 treatment for haemophilia (‘haemophilia’)
The sampling strategy was to interview a sample nationally representative of the different routes
of infection so that similarities and differences across groups and the clinical implications of this
could be ascertained. Patients were written to by their consultant and invited to participate in
the study. Following telephone contact, those agreeing to participate were interviewed at the
hospital providing their hepatitis C care. Travel expenses were paid for participation. Because
of small numbers in some groups and somewhat different approaches to invitation at each
centre, all identified haemophilia and renal patients nationally were invited to participate.
Interview questions were developed from separate focus group sessions held with representatives
from the four patient representative organisations; the Irish Haemophilia Society, the Irish
Kidney Association, Positive Action, and Transfusion Positive. In all, 28 people participated in
four focus groups. Analysis of this information aimed to ensure that the concerns of each group
would be reflected in interviews. 
Response rates
Hospital chart review 
Two hospitals required patient written consent for anonymised chart review. Forty-six percent
of those invited gave permission. In other centres, 25% of all charts were randomly selected.
The system of reviewing charts operated very successfully with 99% of identified charts
available for review.
Demographic profile
The demographic profile of chart review patients is summarised in Table 2.1. A total of 388
charts were reviewed across seven centres; a majority (75%) were patients who had contracted
hepatitis C from anti-D, followed by transfusion (18%), haemophilia (5%), and renal patients
(2%). Most were female (87%) and married (83%). Almost half (49%) worked in the home
while others worked full-time outside the home (26% of the anti-D group, 50% each of the
haemophilia and renal groups, and 34% of the transfusion group). 
______________________________
9 The ‘recall’ group of approximately 150 women who had tested hepatitis C positive using the ELISA test, but negative on 
confirmatory testing using the more sensitive RIBA test. they were recalled in Summer 1998 on the recommendation of the 
Expert Committee on Hepatitis C.
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Table 2.1: Demographic profile of hospital chart review patients 
ROUTE OF INFECTION
Anti-D Haemophilia Renal Transfusion Total
N=289 N=21 N=7 N=71 N=388
Age - median10 (range) 48(26-66) 40(19-74) 47(30-72) 55(20-83) 49(19-83)
Sex (%) - male: female 0:100 81:19 71:29 61:39 13:87
Number of children 
3(0-15) 0(0-4) 1(0-6) 2(0-14) 3(0-15)
-(median (range)
Distance (miles) from 
20(1-190) 50(5-180) 50(1-180) 30(2-180) 20(1-190)
hospital - median (range)
Patient interviews 
Of 373 individuals invited for interview, 139 agreed to participate, of whom 132 were
interviewed during the study11 (response rate: 37%). In hospitals where it was possible to
telephone patients, the response rate was considerably higher than where consent to 
participate had to be indicated by post (61% versus 25%). Response rates are shown by group
in Figure 2.1.
It was intended that interviews would be carried out with 30 people in each of the five patient
groups described earlier. However, in most hepatology units, patients with renal disease were
recorded as “transfusion’ patients and were not identifiable as a distinct patient group. It was
only possible to identify 21 individuals in the renal subgroup to whom invitations could be
extended12. The result was a very small group of renal patients (N=7; 33% response rate). It was
thus regrettably not possible to make reasonable comment on or statistical comparisons with the
renal group, given the small numbers involved. For this reason, in much of the discussion to
follow, information on the renal subgroup is combined with that of the transfusion group.
______________________________
10 the median is a statistical score which divides the group into halves so that half the group’s scores are on or below and half are on 
or above the median. Where there are very unequal balances of scores, it provides a more informative description of the group 
than mean (or average) scores.
11 in two cases parents were interviewed on behalf of patients; a 15 year old male haemophilia patient and a 28 year old male 
haemophilia patient with a learning disability.
12 estimates of the total numbers of renal failure patients with hepatitis C were obtained from the Irish Kidney Association; the 
counsellor has met with 26 patients in the course of her work while the chief executive estimated there were 34 renal patients at 
maximum with at least 6 others having died since diagnosis. Thus over 60% of relevant patients nationally were invited to take 
part in this review.
Figure 2.1: Interview response rate by route of infection
The demographic profile of patients who participated in interviews was statistically compared
to that of the chart review. In terms of patient age, sex, marital status, number of children, and
distance from hospital, there were no significant differences between groups. As the charts were
randomly selected, with selection bias possible at only two centres (where patients were asked
to grant permission), the similarity of the chart and interview group demographic profiles is very
reassuring since it suggests that particular types of patient (for example, older patients or those
living longer distances from hospitals) are adequately represented in the interview study. In
short, the interview group appears to adequately represent the underlying population.
The ‘recall’ group is quite distinct from others in their relatively recent classification as being
positive for hepatitis C and since they have had an initially positive health evaluation followed
by later revision of this diagnosis. Thus they are expected to have fewer and different service
interactions to date. For these reasons, this group is not included in general descriptions of
primary and secondary care services in the following chapters. They are considered in
comparison to other groups regarding clinical and psychological status in Chapter 6.
SECONDARY CARE: HEPATOLOGY UNITS
In each unit, interviews were conducted with the consultant gastroenterologist/hepatologist, the
clinic nurse/nurse counsellor, the clinic secretary, and the clinic counsellor, where applicable.
Semi-structured interviews addressed experiences of, and views on, current service use and
future need for services.
PRIMARY CARE
Interviews were conducted with health board liaison officers, counsellors and general
practitioner (GP) representatives. A nationwide survey of randomly selected GPs was completed.
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TOTAL (N=372) 37
Recall (28) 47
Transfusion (74) 55
Renal (21) 33
Haemophilia (158) 17
Anti-D (71) 46
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Liaison officers 
Interviews were conducted with the liaison officer appointed to coordinate hepatitis C services
in each of the eight health boards. Interviews focussed on patient numbers; requests for specific
services including dental, opthalmic, aural, home support, and counselling services;
confidentiality; and views about current and future needs for hepatitis C services. Detailed
information was provided on numbers registered by route of infection; numbers of children and
partners registered; and the pattern of billing for counselling and home support services.
Counselling 
Counsellors interviewed were those employed by a hepatology unit or patient support
organisation to provide counselling services to the hepatitis C blood product positive group
(N=4). Interviews focussed on demand for counselling services; nature of services; number of
sessions per week allocated to the counsellor; counselling needs of the hepatitis C group and
their families and whether these needs have changed over time; and estimates regarding future
needs of the group.
General practitioners
When hepatitis C was first publically announced in 1994, GPs became the first point of contact
with health services for the majority of patients who suspected they were at risk from hepatitis
C. Most GPs had little experience of hepatitis C and were not briefed to deal with the demand
for testing and counselling services. Two representatives of the Irish College of General
Practitioners (ICGP) were interviewed regarding needs of GPs in relation to hepatitis C;
communication between the secondary care hepatology units and GPs; experiences in relation
to the Health Services Card; and expectations for the future in relation to service needs and the
role of the GP. Following this a national GP survey was developed.
Aim
The aim of the survey was to record GP experiences with this hepatitis C patient group, focusing
on current service adequacy, and future needs and concerns.
Sample
The listing of GPs who had billed for services under the Health (Amendment) Act (1 July 1997
- 30 June 1998) was obtained from the Department of Health and Children (N=548). One
hundred and fifty doctors were surveyed at random from this listing.
Procedure
A self-report questionnaire was developed and piloted following consultation with GP
representatives. A postal survey was conducted with written and telephone reminders. Eighty-
five replies (a 57% response) were received.
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INTERVIEWS AT SPECIFIC RELEVANT NATIONAL AGENCIES
Blood Transfusion Service Board 
This interview with the chief executive officer and consultant haemotologist focussed on
numbers and geographic location of people infected. Effects of the hepatitis C outbreak on the
routine work of the BTSB, specifically in relation to the rates of blood and organ donation since
1994, were also examined. 
Expert Group on Hepatitis C, Department of Health and Children 
The chief medical officer at the Department of Health and Children was interviewed in his
capacity as Chairperson of the Expert Group on Hepatitis C. This group’s remit was related to
recall of persons whose test for hepatitis C (as part of the 1994 screening programme) had been
positive on the initial ELISA test, but proved negative on confirmatory RIBA testing. The
interview focused on present and future management of recall situations in the context of
hepatitis C.
Health Research Board 
The nature of infection of the Irish hepatitis C blood product positive cohort is unique in that
for many individuals the date of their infection is known, and challenges to their pattern of
illness progression are not complicated by other health problems such as intravenous drug use.
Thus, this patient group is highly suited to studies on the natural history and course of the
infection. It is also the case that those who received contaminated blood products but did not
seroconvert to hepatitis C positive can be identified, as can the date of their inoculation with
infected blood products. In short, Ireland has a unique opportunity to conduct research into
hepatitis C that is of significant international importance. The interview with the Health
Research Board chief executive and accountant focussed on HRB’s currently funded research
and on their perspective on the coordination of information relating to hepatitis C in the form
of a national database. Views on how best to disseminate research information to both patients
and professionals were also considered.
Other professionals: consultant pathologist 
A consultant pathologist was consulted regarding diagnostic services for hepatitis C. This
interview focussed on the types and adequacy of tests used for hepatitis C, and on training needs
for pathologists. Demands on pathology services resulting from hepatitis C to date and for the
next five years were examined.
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Chapter 3
SECONDARY CARE SERVICES
This chapter describes services in the hepatology units and other hospital-based services. Service
use was estimated from hospital chart review while patient views on professional service
providers and support organisations were considered from interviews. 
POPULATION SIZE
The first issue to consider in relation to service use is the size of the population being served.
Numbers registered with the seven hepatology units are presented by route of infection in Figure
3.1. The hospital numbers are likely to be an over-estimate since some patients will have
attended more than one clinic. Figure 3.2 outlines the distribution of patients across health
boards. The figures of patients registered with the health board liaison officers are an under-
representation of numbers infected since an indeterminate number of people choose not to
register for free services. Blood Transfusion Services Board numbers are lower still (N=1089)
with incomplete listing, for instance, of the haemophilia group.
Differences in estimates of the population requiring services point to the need for a single agency
to have responsibility for maintaining a complete count of patients in this iatrogenic hepatitis C
group. This list will need to be updated through the coming years when, for instance, a large
group of recall patients will be re-tested. A national register of patient names is one method of
achieving this but one which may raise concerns about confidentiality. More complete
information about patient numbers may assist financial planning in both current allocation of
funds and in estimates of future service demand. It is to be expected that some of those patients
not currently registered or using health board and GP funded services will come in to this system
in the future as, for instance, their health needs increase or the stigma associated with the
disorder decreases.
Figure 3.1: Numbers of patients with iatrogenic hepatitis C infection registered 
with the seven heptology units by route of infection (N=1645)
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Figure 3.2: Numbers of patients with hepatitis C infection registered 
with health boards (N=1268)
HEPATOLOGY UNITS: SERVICE USE AND SATISFACTION 
Medical chart review
The median number of visits to specialist hepatology clinics in the previous year was two with
no significant difference in the numbers of visits made by the different subgroups. As expected,
patients who were PCR positive had significantly more visits to the hepatology clinics13. 
Interview study 
Patients participating in interviews were asked about the number of visits made to a hepatology
clinic and about their satisfaction with the frequency of visits and with the specific hepatology
unit services more generally. Two-thirds of the patients (67%) had attended the clinic for 2 or
more visits in the 12-month period under consideration with about one-fifth (21%) not
attending the clinic in the same period. Satisfaction with frequency of clinic visits was high
(87%). 
The specialist services provided are considered next. 
LIVER BIOPSY
Liver biopsy is described as the ‘gold standard’ test for the assessment of patients with chronic
hepatitis by the US National Institute of Health (NIH) (USA)14. Disease progression has been
monitored by conducting liver biopsy every two years for those considered at risk. However, repeat
liver biopsies at two years have shown little histological change compared to the first results. 
______________________________
13 PCR positive: mean number of visits: 3.04 (S.D.: 2.72). PCR negative: mean number of visits: 1.59 (S.D.: 1.72) (t=6.43, p<0.0001)
14 NIH. Management of Hepatitis C. Consensus Development Conference Statement , March 24-26, 1997.
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For this reason, and because of the health risks associated with the procedure, it is now
considered that liver biopsies should be conducted at five year intervals. This recommendation
is in accordance with the most recent (February 1999) consensus statement of the European
Association for the Study of the Liver (EASL)15.
For this review, liver biopsy information was recorded as part of the chart review process and
interviewed patients were asked about their experiences of liver biopsy. Liver biopsy was also
addressed in interviews with health professionals and patient support organisations. Of 388
charts reviewed, there were 368 biopsies with 243 individuals (63%) having undergone at least
one biopsy. More than one-quarter (27%) had undergone more than one biopsy, 22% having a
second and 4% a third biopsy. Twenty-five percent of those who were PCR negative, compared
with 88% of those who were PCR positive, underwent liver biopsy. 
The majority (73%) of biopsies have been carried out on the anti-D group, with only 5
individuals in the haemophilia group (24%) undergoing one biopsy each. For many patients,
their initial biopsy will also be their most recent. Results of the most recent biopsies are
presented in Table 3.1. Hospital pathologists, when compiling biopsy reports, provided the
disease severity classification. It is important to note that percentages relate to the percentage of
the population indicated who had biopsies and not to percentages of that population as a whole.
It is not possible to conclude from the information available that evidence of liver disease
documented relates only to Hepatitis C16. Proportions of patients at different stages of severity
of liver dysfunction do not change from first to latest biopsy.
Table 3.1: Result of most recent biopsy by infection route and PCR status
BIOPSY RESULTS – SEVERITY CLASSIFICATION
PCR status by route Normal Mild/mild- Moderate/ Severe Other
of infection (N) % moderate moderate- % %
% severe %
Anti-D
PCR positive (162) <1 80 17 1 2a, b
PCR negative (32) 22 59 6 0 13
Haemophilia
PCR positive (5) 40 20 20 20c
PCR negative (0)
Transfusion
PCR positive (39) 72 15 5 8a
PCR negative (5) 20 60 0 0 20d
Total (243) 4 70 18 3 5
ano information, results not stated (N=8); binadequate specimen (N=2); creport missing (N=1); 
dresults not available at time of review (N=1).
______________________________
15 European Association for the Study of the Liver (EASL) Consensus Statement, EASL International Consensus Conference on 
Hepatitis c. Journal of Hepatology 1999; 30:956-961.
16 Kay E. O’Dowd J. Thomas R et al. Mild abnormality in liver histology associated with chronic hepatitis: distinction from normal 
liver histology. Journal of Clinical Pathology 1997, 50:929-931
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Outcome of liver biopsy by disease status is outlined in Table 3.2. Test results from both the
haemophilia and transfusion groups have evidence of more advanced liver disease; 20% and
21% respectively have evidence of cirrhosis when compared with 6% for the anti-D patient
group. However, as detailed previously, there are differences in the proportions in each patient
group who have had a biopsy. The small percentage of biopsies for haemophilia patients, given
the particular difficulties of risk of bleeding associated with undergoing liver biopsy for the
haemophilia group, mean that it is more likely that those who undergo the procedure have
strong clinical indicators for biopsy, in terms of more advanced disease. If it was assumed that
those not tested have no evidence of disease, then proportions with evidence of cirrhosis would
be quite different at 4% (anti-D), 5% (haemophilia), and 10% (transfusion). 
Table 3.2: Evidence of disease status in biopsy reports, by route of infection 
and PCR status
EVIDENCE OF DISEASE
PCR status Numbers Hepatitis Necrosis Fibrosis Cirrhosis Cancer
by route of having
infection(N) biopsies
Anti-D
PCR positive 162 99 61 43 4 0
(164)
PCR negative 32 69 30 27 2 3
(125)
All anti-D 194
(67%) 6
Haemophilia
PCR positive 5 80 60 60 20 0
(14)
PCR negative 0
(7)
All
haemophilia 5 (24%) 20
Transfusion
PCR positive 39 100 49 46 21 0 
(57)
PCR negative 5 60 40 20 0 0
(21)
All transfusion 44 (56%) 21
Total (N=388) (243) (231) (131) (99) (18) (1)
% 63 95 54 41 7 0.4
Conclusions about overall disease status and disease progression are discussed further in
Chapter 6.
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Liver biopsy: patient interview information
Liver biopsy is considered a stressful medical procedure both because of the invasive nature of
the procedure and because of the possibility of negative long-term implications of test results.
This section reviews patient experiences of biopsies including satisfaction with treatment.
Overall satisfaction with management of liver biopsy
Most patients (77%) were satisfied with their overall experience of biopsy. This finding did not
differ significantly across patient groups. However, 17% expressed dissatisfaction.
Opportunity to prepare for, and recover after, biopsy
The Health Care Package (1995) allows for inpatient stay before and /or after biopsy tests to
facilitate patient preparation for, and recovery from, the procedure. In this group, the largest
proportion (45%) spent only the night after biopsy in hospital, closely followed by the number
of patients spending overnight the night before and after in hospital (32%). All haemophilia
patients had at least two nights in hospital for the procedure.
The majority of patients (84%) were satisfied with the length of time spent in hospital for
biopsy, with no significant differences across patient groups. Satisfaction with liver biopsy
management did not vary significantly according to length of time spent in hospital.
Location in hospital for biopsy admissions
The Health Care Package (1995) specifies that hepatology units should have a designated ward
area for patients admitted for testing, treatment, or biopsy. In five hospitals one bed is protected
for this group. Another hospital has two beds reserved, if required, while the remaining hospital
is still in the process of establishing services. Half of the group interviewed here (51%) were
admitted to a designated hepatology ward area; however, a large proportion of patients (41%)
were admitted to a general day ward.
The majority of patients (76%) were satisfied with the area to which they were admitted for
biopsy. This did not vary significantly across patient groups. General satisfaction ratings did not
vary significantly according to type of ward. However, extreme dissatisfaction was expressed by
a much higher proportion of those staying in a general day ward compared to a designated
hepatology ward (30% versus 3%).
High levels of satisfaction were also indicated regarding communication aspects of the patient
experience of liver biopsy. A majority of patients were satisfied with the knowledge and
expertise of staff associated with their biopsy (94%), information received regarding biopsy
results (78%), and the manner in which results were communicated (83%).
Patient proposals about improving liver biopsy procedure
When patients were asked about how the experience of liver biopsy could have been improved,
a preference for more privacy was the most commonly quoted suggestion (19%). Nine patients
(14%) wanted more information about the procedure and 11% wanted more support from staff
while in hospital for biopsy. 
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Interviews with Professionals
Consultant hepatologists
Discussion with consultant hepatologists in relation to liver biopsy focussed on their approach
to communicating biopsy results to patients. Without exception, consultants said they
communicated biopsy information to their patients with verbal descriptors rather than scores.
Consultants reported being subjected to considerable pressure from legal counsel involved in the
Compensation Tribunal to provide scores from biopsies since information in the form of a score
was seen to have greater meaning in the Tribunal context than a verbal description. However,
in the clinical context, the consensus was that there is a considerable margin of error in current
biopsy scoring techniques. The concern was about providing biopsy score information to
patients, such that patients may perceive a change in liver status based on test scores, when in
fact the pathologist and hepatologist are satisfied that the patient’s status is stable. Biopsies
taken from different parts of the liver at the same time may yield different test scores. For this
reason, all hepatologists stated that they give biopsy results to patients in terms of ‘mild’,
‘moderate’, or ‘severe’, and then outline the significance of the result in terms of current status
and prognosis. Information is subsequently sent GPs in the same way. 
Consultant pathologist
Irish pathologists involved in the examination of hepatitis C-related tests met regularly for some
time following the 1994 announcements to determine protocol and procedures for the
monitoring of hepatitis C infection. It was agreed at these meetings that liver biopsy scores
should not be provided by pathologists in routine reporting of biopsy results.
It is interesting to note the high levels of patient satisfaction with information on biopsy results
(78%) in a context where consultants uniformly do not provide numerical results. This occurs
alongside very differing opinions about the necessity for communication of numerical biopsy
results across support organisations.
Patient Support Organisations
Representatives noted differences between units in how biopsy procedures are managed. For
instance, in some hospitals, patients are admitted fasting, have the biopsy, and are released the
following day; in others, patients are admitted the night before and discharged the next day.
There was concern that patients may be discharged too quickly17. A number of issues were raised
regarding communication. A booklet about the procedure was recommended as necessary to
fully inform patients. 
______________________________
17 Recently published recommendations advise that patients can be discharged home after six hours if there are no complications and 
if the patient has a ‘responsible person’ to stay with on the first post-biopsy night and is able to return to hospital within 30 
minutes if necessary (Grant a. and Neuberger J. Guidelines on the use of the liver biopsy in clinical practise. Gut 1999; Suppl. IV: 
IVi-IVxi.
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TREATMENT WITH INTERFERON
Treatment of active hepatitis C has been with interferon. Information on combination therapy
with ribavarin is less common than treatment with interferon alone to date.
Interferon: chart review information
Of 388 charts reviewed, 18% had records of treatment with interferon therapy; two patients
had combination therapy. Of those receiving interferon, 31% continued treatment for 3–6
months, 44% for 7–12 months, and 13% for more than 12 months. Two percent of patients
were unable to tolerate treatment for the minimum recommended three months and
discontinued. 
The outcome of interferon treatment is presented in Table 3.3. For 47%, hepatitis C status did
not change following treatment and for a further 25%, initial response to treatment was not
sustained. Thus, sustained benefit from interferon therapy was present in 26% of patients
undergoing treatment.
Table 3.3: Outcome of interferon treatment
Treatment No change PCR negative PCR negative No 
not (%) status status information
tolerated maintained achieved but %
(%) (%) relapsed (%)
Route of infection (N)
Anti D (38) 0 40 32 28 4
Haemophilia (6) 0 100 0 0 0
Transfusion (16) 6 44 25 25 0
Total (60) 2 47 26 25 0
Interferon: patient interview information
The majority of patients (70%) for whom anti-viral therapy was an option felt they had been
offered a choice as to whether or not to undergo treatment. However, 18% did not agree. Where
lack of choice was reported, it involved both patients feeling a requirement to participate in
treatment as well as patients feeling they had not been offered treatment.
Provision is made for a stay in hospital of up to five nights when interferon is initiated under
the terms of the Health Care Package (1995). Thirty-eight percent of those who had undergone
interferon treatment reported being offered the opportunity to stay in hospital while 62% had
not. Most patients (66%) did not spend a night in hospital; 13% stayed one night with 12%
staying five or more nights. 
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For those who underwent interferon treatment, a majority of patients (63%) felt that they had
been fully informed about the process of undergoing interferon therapy. Somewhat fewer (55%)
felt that they had been adequately informed about the side-effects of treatment. Twenty-three
percent felt that they had been given conflicting advice about receiving interferon from health
professionals. Approximately 20% of those interviewed were ambivalent about the information
and advice they were given in relation to interferon, with 20% dissatisfied with the information
and advice given. A majority of the group (77%) reported being satisfied with medical care
while on treatment. However, satisfaction levels were considerably lower (40%) in relation to
counselling support available from the medical team while on treatment. 
Twenty interviewed patients had declined interferon treatment. Patients who had declined
treatment were asked to indicate their satisfaction with the knowledge and expertise of the
medical staff and the medical and counselling support available to them following their decision.
There was little reported dissatisfaction (5-9% respectively) but a majority (52-58%) were
ambivalent about support received.
Patient Support Organisations
Patient difficulties in choosing and fully understanding what is involved in interferon therapy
were reiterated in support organisation interviews. Representatives felt that individuals were not
being fully informed of the side-effects and potential long-term effects of treatment for hepatitis
C. Written information was seen as a useful component of overall care for patients undergoing
interferon. The need for adequate support during commencement of therapy was stressed.
Regular contact at home, particularly to assist regarding side-effects, was seen as important for
continuity of care. Support organisation interviews highlighted a sense of pressure being brought
to bear on people to undergo treatment. This was seen to emanate in part from a belief that
patient response to interferon treatment could be an important consideration in deciding
financial settlement in the Tribunal of Compensation. 
Interviews with Professionals: Secondary Care Providers
Centres reported offering patients the option of admission to hospital when commencing
treatment. However, their experience was that most patients opted not to stay overnight.
Therefore, the majority of patients commenced on interferon as out-patients. 
Overall, the perception of clinic staff was that the current service in relation to interferon was
operating satisfactorily. Concern was expressed, however, about the anticipated demand on
clinics by increasing numbers commencing treatment, particularly as use of combination therapy
becomes more widespread. Unless resources are made available to cater for this increased
demand, clinic staff anticipated difficulties in maintaining a quality service. The mismatch in
perceptions of service adequacy between patient and advocate groups and those of professionals
is cause for concern, particularly given the challenging course of interferon therapy for the
patient involved. This may become more critical given that the upcoming treatment choice –
combination therapy with ribavirin – can be even more difficult to tolerate. It is therefore
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important that challenges facing those on anti-viral therapy, in particular management of side-
effects, be monitored on an ongoing basis.
Biopsy and anti-viral therapy are two key aspects of the management of this patient group and
as such require ongoing evaluation.
Recommendation 1: That a committee be established to agree treatment
protocols (including liver biopsy procedures and scoring, and administration of
anti-viral therapy) for this particular group. The committee should comprise the
medical consultants with primary responsibility for this group of patients and be
chaired on a rotating basis.
OTHER HOSPITAL AND SPECIALIST SERVICES
Thirty-six percent of interviewed patients had another chronic illness besides hepatitis C (and
their index condition, i.e. haemophilia or renal disease). A profile of use of other hospital
specialties was documented from the review of charts. The service to which the highest number
of referrals was made was rheumatology; 9% of the group having had a referral to this specialist
area. Referrals to specialist gynaecology and ophthalmic services followed rheumatology (5% to
each). Overall use of specialist services by this patient group was low especially considering the
prevalence of other chronic illness.
Valid quantification of patient satisfaction with specialist services aside from specialist
hepatology services was not possible since such a wide variety of services was used.
Hospital admissions
Fifty-four people had one admission to hospital in the 12 month period examined in the chart
review. A further seven had two or more admissions (16% of admissions in total). Of those
having hospital admissions in the year, 57% were anti-D, 33% were transfusion and 10% were
haemophilia patients. Thirty-one hospital admissions were for liver biopsy and two for
commencement of interferon therapy. The remainder were primarily short-term admissions for
investigations.
Staff at all centres were concerned about the availability of physiotherapy services, particularly
into the future. Current scarcity of physiotherapy services in hospitals was seen as particularly
problematic for rheumatology services as the most used other specialty by the hepatology units.
Regular access to physiotherapy where needed was also seen as problematic if available only at
hepatology unit locations. Allowance for provision of physiotherapy services at community
level, including use of services of chartered physiotherapists in private practice, could increase
access to services both in number and proximity.
Priority access to other specialist services is via the ‘two-week rule’. The ‘two-week rule’ refers
to the specification in the Health Care Package (1995) that individuals infected with Hepatitis
C via State-provided blood products “will be given a priority appointment within two weeks for
the first consultation”. Details of the regulations have been circulated to medical consultants by
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some health boards and hospitals. There were problems with the implementation of this
recommendation in most hospitals. Most problems were reported as relating to the fundamental
principle of operating a different system for this group of patients. When referral worked well,
this often depended on good working relationships, for instance among secretarial staff, in these
services. Thus there can be a reliance on relationships rather than on systems. 
Recommendation 2: That the system whereby patients are referred by their
consultant hepatologist to another specialty be regularised to facilitate
Hepatology Unit staff in making priority referrals in accordance with the ‘two-
week rule’. A comprehensive referral system for physiotherapy should be
established to ensure that it is available to all who require it.
MANAGEMENT OF DEATH
The management of death and of the remains of the deceased person was raised by professionals
and support organisations since there was seen to be confusion regarding regulations concerning
management of persons with hepatitis C following death. There was concern to ensure that
hospital and funeral practices should be guided by clearly stated and evidence-based protocols
rather than by individual preference or custom. Such a protocol should serve to reduce anxiety,
where this might be a concern, for funeral workers and should also serve to prevent
inappropriate and insensitive management of this particularly difficult issue for the individuals
concerned and/or for their families.
Recommendation 3: That guidelines be developed for the management of death,
including funeral arrangements, so that the necessary safe practices are
understood and accepted by all concerned.
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Chapter 4 
PRIMARY CARE SERVICES
Primary care services for this group are coordinated by health board liaison officers. These
liaison officers, one in each health board, were specifically appointed to oversee the
implementation of the Health Care Package (1995).
The liaison officer role
This role was established to enable efficient delivery of many primary care services including
access to Health (Amendment) Act (1996) services. The positions have required a dual
educational role of informing health board associated personnel of entitlements under the
Health (Amendment) Act (1996) and of developing literature and clarifying requests from those
eligible for services under the Act. It appears to have worked well from the perspective of liaison
officers themselves. The view from health professionals and support organisations has been
extremely positive with liaison officers seen as ‘brokering’ a link between anxious individuals
and an unwieldy system. Indeed the liaison officer role was seen as one of the strengths of the
system developed to support this particular group of patients following from their iatrogenic
infection. The continuing contribution of this group was seen as important.
Recommendation 4: That health board liaison officers meet on a regular basis
to ensure uniformity and continuity in the provision of primary health care
services.
COUNSELLING SERVICES
The role of counselling services
Counselling is a key concern regarding services for hepatitis C. International research has shown
high levels of psychological distress among patients with hepatitis C. Counselling has been seen
as an appropriate service to make available in Ireland given the psychological demands of
coping with the health consequences of infection with the virus, combined with the effects of
being iatrogenically infected and discovering about one’s infection in the highly-charged
environment of significant media and political attention. The importance of this service is
emphasised by its specification in detail in the Health (Amendment) Act (1996) documentation. 
Counselling service provision by hepatology units
Patients needing psychosocial services over and above the support provided by medical and
nursing staff were served by a varied arrangement of options across units. As with other medical
patients, patient files for psychiatric referrals are recorded and stored separately from general
medical records. It was not possible to ascertain the number of psychiatric or clinical psychology
appointments availed of as part of service use by this group. Of 388 medical charts reviewed,
there was some mention of counselling in 15% but even here it was not clear if counselling was
simply considered, was discussed with the patient or was scheduled. For the future, availability
of this information, especially regarding decisions to refer and use more specialist psychological
and psychiatric services, will be important if patterns of serious psychological or
neuropsychological problems are to be monitored. 
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Counselling service provision in primary care
Service provision on a health board basis is organised by boards identifying lists of qualified
counsellors and reimbursing patients for services availed of through them. Uptake of these
services across health boards is reimbursed by liaison officers and is presented in Figure 4.1.
FIgure 4.1: Counselling services funded by health board through the liaison officer
system
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Figure 4.2: Average number of counselling sessions provided by health boards
Two-hundred and four patients (16%) availed of 1,457 counselling sessions in the year with 20
relatives availing of an additional 38 sessions (July 1997-June 1998). A total of 44 counsellors
provided services across the health boards. Figure 4.2 outlines session use across boards.
General practitioners may provide counselling as part of their broad service provision for
patients. Twenty-three percent of visits to surveyed GPs were for general counselling by the GP
while another 8% of consultations were to provide administrative support for patients availing
of specialist counselling services. 
Three of four support organisations had specific organisational resources for counselling.
Counsellors were already employed by the Irish Haemophilia Society and Irish Kidney
Association; organisations which had been in existence for up to three decades before the
announcement of this hepatitis C issue. Apart from formal counselling, a number of informal
groups and activities exist which provide support to individuals. These were hospital or support
organisation based. Counselling services were available and accessible from a number of health
settings: hepatology centres, health boards and general practitioners, as well as patient support
groups who could recommend counselling services.
Perspectives on and experiences of counselling services
Explicit access to, and provision for, counselling services in the context of a physical disorder is
a departure from the usual experience of most Irish health professionals and administrators.
This is especially so on the scale allowed for in this situation. The views of health professionals
and those facilitating access to the services are all the more interesting in this context. The
general view of health professionals and support organisations was that counselling as a service
was working well. Regarding the functioning of counsellor lists, they were seen to work well in
most settings with general agreement that the services provided and the staff providing them
were of high standard. In some health board regions, coverage was seen to be available but with
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little or no choice of counsellor or location of service. The psychiatric setting was seen as an
inappropriate location for service by some patients and support organisations.
Recommendation 5: That health board liaison officers ensure choice of
counsellors and counselling locations in all health board areas.
Acceptability of counselling and associated services
Patients were often seen as reluctant to avail of counselling but the general experience of staff
was that patients who did seek counselling were glad in retrospect that they had. A view widely
expressed was that counselling service independence from the Blood Transfusion Services Board
has made for a more acceptable counselling service in recent years.
In total, 51% of the sample availed of counselling at some time since diagnosis. There were no
significant gender differences in proportions of those availing of counselling services; 53% of
women and 45% of men availed of services. 
Of those who had availed of counselling services, a majority (75%) also intended to use these
services in the future. This is noteworthy since it might be perceived that individuals not
otherwise requiring or desiring counselling may have attended previously as part of their
Compensation Tribunal preparation and would not wish to continue with service attendance in
the future.
Most of those who used services rated them as being of high quality (82%). A significant
minority however were dissatisfied (18%) (see Table 4.1). 
Table 4.1: Problems encountered regarding counselling for those availing of services 
Problem Major problem Minor problem No problem
(%) (%) (%)
Initial reluctance to 
attend counselling 26 31 43
Distance required to 
travel to the service 22 20 58
Actual location of the 
service 15 11 74
Waiting time to get 
an appointment 18 7 75
The most common problem in attending counselling; reluctance, was evident in similar
percentages (57%) across patient groups18. Reasons for not attending counselling included
patients feeling they had no need for the service (68%), that the services were inconvenient for
them (10%), that services were not offered (13%), and a belief that the
______________________________
18 (χ2=1.13, df=4, p=0.89, i.e. no significant difference across groups).
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not of high quality (9%). Thus most people not using services did not wish to do so despite
availability.
In conclusion, counselling services were generally seen as working well by both providers
and users.
HOME SUPPORT SERVICES
The Health (Amendment) Act (1996) provides for “home help services within the meaning of
Section 61 of the Health Act (1970) to be provided free of charge to persons who contracted the
hepatitis C virus through State-provided blood products. This enables people to avail of home
support19 services. Although no limit on service use is specified, there exists a working definition
of a maximum of 20 hours per week. The views of professionals, support organisations, and
patients on this service are outlined. 
Home support services are generally managed through the health board liaison officers. The
issue of who provides home support is unique to this patient group. In all other circumstances,
home support is provided by individuals employed by the health board. However, those holding
a Health Services Card have the option of appointing their own home help. At present, 62% of
those availing of home help services have nominated their own home support. Availing of home
support raised challenges for patients regarding confidentiality of their diagnosis of hepatitis C,
and health board challenges regarding training, safety, and direct employment of those
providing the service.
There is a strong argument that the home support provider does not need to know the health
details of the person concerned as firstly, it does not impinge on the service required, and
secondly, the person availing of the service is entitled to confidentiality regarding health matters.
On the other hand, health boards have a duty of care both to the patient and to the person
providing home support. Health and safety may not be an issue if proper training for infectious
disease control is provided to people working as home supports. Very little training is currently
given to home support providers; at minimum training should be provided in universal
precautions regarding infectious diseases.
Recommendation 6: That a general training programme for all home support
providers be available. This programme must have as a basis an agreed strategy
regarding the balance to be achieved between duty of care to the provider and
the right to confidentiality of health information of the recipient.
______________________________
19 use of the term ‘home support’ was advised to distinguish this service and its different conditions of operation from the general 
‘home help’ service.
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Different rates of pay across health boards have created difficulties20. In situations where the
person has chosen to pay the home support provider directly, they adopt the role of employer
and, as such, become liable for PRSI payments and also for insurance liability for the individual. 
Recommendation 7: That the issues surrounding the difficulty in recruitment of
home support providers, including remuneration issues, be reviewed to ensure
availability of the service to all who require it.
Liaison officers provided detailed information to the Review on use of home support services in
their health board area for the 12 month period from 1 July 1997 to 30 June 1998 (this is
summarised in Figure 4.3). In total, 24% of this patient population availed of home support
services. Of those, the average time per week availed of was 9.7 hours (see Figure 4.4 for use
across boards). If these figures were applied across the overall population of people with
iatrogenic hepatitis C infection, home support requirements at present amount to an average
weekly requirement of 1.5 hours per person. The potential for an increase in demand for home
support in the future is substantial (18.5 hours per person infected per week or more than twelve
times the current level of use if a working upper limit of 20 hours per week is considered).
Liaison officers endorsed the view that there is likely to be a significant increase in demand for
home support services in the future, based on people becoming older and/or ill. What is most
striking about these figures is the very low uptake of a discretionary service some four years after
it was made available.
% patients availing of home support
Figure 4.3: Patients availing of home support services by health board 
(July 1997 - June 1998)
______________________________
20 a national system of payment of £4.40 per hour for home support providers was announced by the Government in November 1999.
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Figure 4.4: Average hours of home support availed of by patients per week by health
board (July 1997 - June 1998)
Overall, 20% of the population surveyed had been offered home support services. Somewhat
more than that (25%) had availed of the service at some time, with a further 16% stating that
they would like to avail of the service in the near future, but were not currently doing so. It is
noteworthy that 59% neither use nor intend to use these services in the near future (see Figure
4.5 overleaf). Of those not availing of home support, a majority (76%) said they were not
accessing the service because they had no need for it. A further 12% said they lacked
information about the service, while 3% had encountered difficulties with health boards. Nine
percent of patients interviewed said they saw the service as a threat to their privacy. Most of
those who had availed of home support reported a high level of satisfaction with the service
(87%). Nonetheless, a sizeable minority (18%) reported being quite/extremely dissatisfied. 
GENERAL PRACTITIONER SERVICES
Background
There was wide acknowledgment of the difficult position that GPs were placed in following the
sudden announcement of the hepatitis C issue in 1994. The dilemma facing the Department of
Health and Children and the implications of the decisions taken have already been addressed in
the Report of the Expert Group on the Blood Transfusion Service Board (1995)21. Its relevance
here relates to its impact on current GP service provision and the perception of same by GPs and
others. The GP-patient relationship was seen to have been exposed to potential damage
______________________________
21 This will provide an estimate but there are an indeterminate number of cases (see section concerning liaison officers) where eligible 
patients have not applied for a Health Services Card, either paying directly by themselves or perhaps availing of a pre-existing 
medical card eligibility. 
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Figure 4.5: Current and Estimated future use of home support services by route of
infection
following the hepatitis C announcement in 1994 when GPs were not provided with up-to-date
advice for some days after the news release – days in which they may have found it difficult to
inform anxious patients in a manner they would have desired. Subsequent GP visits could, it was
felt, be seen by GPs, patients, and others as an attempt by those affected to increase their cases
for compensation in the Tribunal. Thus there were ongoing challenges to maintaining or
developing a good relationship with a GP which were outside the control of both patient and GP. 
GP provision of and views of services
There were very differing views on current GP interest in involvement with this group of
hepatitis C patients. On the one hand, it was believed that GPs feel ‘out of their depth’ and
would prefer to leave care to specialists while patients ‘want to see the consultant’; on the other
hand, hepatitis C was seen as one of many relatively rare conditions managed by GPs who can
avail of specialist information while providing care in the wider context of the patient’s family,
background and aspirations.
The level of service provision by GPs to this group was considered by examining the number of
medical consultations billed to the General Medical Services (Payments) Board within the
provisions of the Health Services (Amendment) Act through the Health Services Card22. Between
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1 July 1997 and 30 June 1998, 576 doctors billed for services provided. A total of 7308
consultations were billed for (average: 12.7 [SD 14.3] per doctor; median 8 [range 1-103]).
From the national GP survey, 73 GPs currently cared for 152 patients with iatrogenic hepatitis
C infection with 19 having a total of 104 patients infected with hepatitis C through other routes.
Most clinical contact was for routine care (30%), GP counselling (23%), and administrative
support to access specialist services (15%). The majority of GPs (86%) had experienced no
difficulties with their patients’ use of the Health Services Card. 
Patient views of GP services 
Almost all patients interviewed (95%) had a GP whom they attended regularly. Most patients
(72%) used the GP service for all health problems, whereas others visited their GPs only with non-
hepatitis C related concerns. Difficulties with GPs were reported by 19% of patients, with 19%
having changed GPs since diagnosis. Current GPs were seen as adequately informed about
hepatitis C by 62% of patients. Levels of general satisfaction with GPs were high with 89%
reporting being quite or very satisfied and with little variation across routes of infection. This level
is somewhat higher than reported in a large recent study of public satisfaction with GP services in
two health boards (81%)23. It illustrates a satisfactory match between patient expectation and GP
service provision at present despite earlier difficulties for this hepatitis C group. 
DENTAL SERVICES
There has been confusion about dental service eligibility for this group in the past. The situation
is now viewed as much improved with information provision through the principal dental
surgeon network to colleagues clarifying eligibility criteria. 
Most patients interviewed (83%) reported experiencing difficulties with dental services since
diagnosis, with many (28%) changing dentists. Sixty-four percent felt their current dentist was
adequately informed about hepatitis C. Support groups were concerned that dental decay
resulting from medications taken for related conditions is not currently covered in the services
provided. Because of this, they felt that service coverage should be at least the same as that
available through PRSI24 eligibility. 
A small number of dentists have been reported as unwilling to treat this group. This has been
managed at health board level by the creation of lists of dentists actively participating in the
scheme. This was seen as a source of stigma for patients. Most stigmatising for patients was
being seen ‘last on the list’. This applied in a number of settings including dental care. While
some individuals found this practice acceptable - provided there was adequate and sensitive
explanation - there was a sense that it was a measure over and above the necessary, which again 
______________________________
22 this will provide an estimate but there are an indeterminate number of cases (see section concerning liaison officers) where eligible 
patients have not applied for a Health Service card, either paying directly by themselves or perhaps availing of a pre-existing medical
card eligibility.
23 Millar M. Patient satisfaction with general practice in Ireland. Irish Medical Journal (in press).
24 PRSI: Pay related State-funded service to those paying insurance in employment.
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people found stigmatising. Nine percent of patients reported extreme dissatisfaction with their
dental services while another 10% were quite dissatisfied - a high level of overall dissatisfaction
compared with GPs (9%).
OPHTHALMIC AND AURAL SERVICES
Eye testing is covered under the Health Services Card with a contribution of £30 towards
frames. While there is no waiting time for the Sight Test Scheme, essential in-hospital treatment
(although unusual to date) was associated with long delays. Most patients interviewed for the
study (72%) had visited an optician since diagnosis of hepatitis C. Few had difficulties with
these services. General levels of satisfaction with these services were high (only 7% dissatisfied).
There have been very few requests for funding of aural services. However, the cost of hearing
aid provision has been noted as considerable should demand increase.
For all of the above (dental, ophthalmic and aural services), health board liaison officers felt that
services were being used in proportion to need.
PHARMACY SERVICES
The majority of patients interviewed (91%) regularly used a local pharmacy. Nine percent
however used a pharmacy at a distance from their homes, mostly for the purpose of protecting
their privacy. When asked about the possibility of being identified as a Health Services Card
holder on a nationwide computer database, 50% of patients said that they would find this either
‘very helpful’ or ‘helpful’; another 46% had ‘no opinion’ on this issue. In general, pharmacy
services were seen as discreet in their service provision (11% having concerns). Somewhat more
were concerned about being seen using the Health Services Card (30%). Levels of satisfaction
with service provision were very high with 7% reporting dissatisfaction.
Recommendation 8: That staff in all primary care disciplines dealing with this
patient group (including general practitioners, dentists, and pharmacists) be
adequately informed about both the actual risk of transmission of hepatitis C
and the guidelines on universal precautions against transmission of infection;
this is to ensure that such patients are treated in a sensitive manner.
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COMPLEMENTARY THERAPIES
The use of complementary therapies is part of a wider development in health service use.
Although national Irish data is unavailable, about one-third of all American adults are reported
as using unconventional or complementary medicine in any given year25. Users are typically
younger, more educated, and in higher income categories. Of those visiting doctors for medical
conditions in a national US survey, 28% also used some complementary treatment with most of
these (72%) not reporting this to their doctors. The use of alternative or complementary
therapies was of considerable interest to this Review. Such therapies can be used both for their
direct effects on ill-health and for management of symptoms. In the hepatitis C setting,
complementary therapies are not funded by the Health Services Card and there are differing
views regarding both the appropriateness of such services and their funding.
Twenty-two percent of the interviewed group had tried complementary therapies. No single
form of complementary therapy was particularly predominant (e.g. 7% had used aromatherapy,
6% massage, and 6% Chinese herbal medicine). Most consultants (consultants of 62% of all
those who had tried complementary therapies) were aware of their patients’ use of
complementary therapies and most consultants were seen by their patients as being supportive
of the practice.
Consultants were agreed in their serious concerns about the use of acupuncture (because of
concerns regarding needle use and spreading infection) and of ingested remedies such as
homeopathy, herbal remedies, and supplements (because of their inadequately investigated and
possibly toxic effects on already compromised liver function). Most health board liaison officers
have had only a small number of enquiries about complementary therapies. A small proportion
(3%) of GP contacts with patients in the previous year were classified as providing
complementary therapies. Support organisations were very favourably disposed to
complementary therapies and were very anxious to have them reimbursed. 
Complementary therapies appear to have reached a pivotal point where some professionals and
locations provide endorsement of facilities and others do not. Debate about the role of
complementary medicine in national health systems is currently taking place in a number of
European Union Member States and in North America (Belgium has just legitimised the
provision of a number of alternative therapies in general health settings, for instance). This
matter needs to be dealt with as part of a wider debate on funding evidence-based health services
and, as with recent consideration of funding should call on information about decision-making
strategies and evolving practices in countries similar to Ireland. In this evolving situation, official
inaction is likely to result in widespread coverage of practices already funded in some settings
on the basis of maintaining equity of service access across regions rather than on considered
advice about the relative merits of a variety of State-fundable services.
Recommendation 9: That the role of complementary or alternative therapies in
the management of hepatitis C be reviewed as part of a wider framework of
evaluation of the use of such therapies in the Irish health system.
______________________________
25 Campion E.W. Why unconventional medicine? New England Journal of Medicine 1993; 328: 282-283.
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Chapter 5
RESEARCH ON HEPATITIS C IN IRELAND
Research is an essential aspect of management of a little-understood disease such as hepatitis C;
a disease formally known to the medical research community for only a decade. Many aspects
of the disease and its treatment remain to be investigated. About one-third of the group
interviewed had previously been involved in research with all but two of those involved in other
hepatitis C research projects. Their experience of research was typically positive (73%) with
only two individuals finding the experience negative.
A positive approach to research in Ireland was one shared by the support organisations. Their
view was that as a unique clinical group, they themselves might not directly benefit from some
of the findings of such work but that “someone should”, as a way for them to gain some sense
of a lasting benefit from a personal and national health crisis. The hospital consultant group
were uniformly agreed about the imperative for research in this area and most were actively
involved in programmes of research; primarily clinical (laboratory) research, and research on
changing clinical profiles of the patient group and on psychological well-being. A listing of
current Irish research projects on hepatitis C is included in Appendix 2. The major funding
source for hepatitis C research is the Health Research Board. Projects have been funded on a
peer review basis both through the general annual call for applications to their grant award
system and through provision of additional dedicated funding of £1,000,000 from the
Department of Health and Children in 1996. The Department of Health and Children, as part
of the Health Care Package (1995), are committed to providing dedicated funding to the Health
Research Board beyond the period of current projects.
A key constituent of coordinated national research on hepatitis C is a national database of
patients. The Cork University Hospital group has developed a national database from within
their own funding resources. There was enthusiastic support for the concept of a national
database from clinicians at all centres. The view of the majority was that a national database
should be managed independently with most clinicians themselves proposing the Health
Research Board as a national independent organisation to maintain such a database. 
Discussions with Health Research Board officials clarified that they already operate national
databases in a number of sectors and that they could provide a coordinating role for such a
database, in association with hospital consultants and relevant others who would have
responsibility for developing the database framework and providing and updating information
from their centres. 
Recommendation 10: That a national database be established for research
purposes; this to be located at an independent coordinating agency and run in
association with relevant groupings.
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Chapter 6
HEPATITIS C: CURRENT STATUS AND SERVICE NEEDS IN THE
FUTURE
The current state of knowledge on the natural history of hepatitis C is scant, with available data
confounded by factors such as other health conditions (for example, haemophilia) or lifestyle
(for example, intravenous drug use). The hospital chart review of almost 400 randomly selected
patient records nationally provided an opportunity to examine current disease status and
information relating to disease progression. 
CURRENT CLINICAL STATUS: LIVER BIOPSY
Hepatitis C follows a highly variable disease course. Ideally, the progress of hepatitis C requires
monitoring at a level at which liver pathology can be assessed. The only satisfactory method of
doing this is taking a biopsy. Since liver biopsy is an invasive procedure, biopsies are only done
when needed to inform clinical management of disease. 
Data was available for 388 patients, of whom 70% were women. Thirty-nine percent were PCR
negative; that is, they showed evidence of acute hepatitis C without having developed chronic
disease. Of the remaining 61% of patients (N=235), 179 could be classified according to severity
of disease. Of these, one-fifth had chronic hepatitis C with normal serum ALT26, half had chronic
mild disease (26% of all test results), and the remaining three-tenths had chronic
moderate/severe disease (16% of all test results). 
Changes in disease over time
Liver biopsy results from this patient cohort underline two important factors: the first is that a
single biopsy is not a definitive statement about the severity of disease: many patients had repeat
biopsies whose results were better than the initial biopsies. Some of these may represent a
reduction in disease activity, but others may simply reflect the fact that a liver biopsy is carried
out by extracting a very small piece of a very large body organ; it cannot be expected to give a
definitive picture. The second important feature is that the rate of deterioration visible in the
biopsy data is too slight to quantify with any degree of reliability.
No biopsy data from the time of diagnosis were available on almost 40% of patients. In terms
of conclusions about prognosis, the first important point is that 39% of patients were PCR
negative; that is, they had no evidence of active hepatitis C virus. The prognosis for such patients
is good; long-term follow-up in other studies indicates that the great majority will have cleared
the virus permanently27.
______________________________
26 Serum ALT is a non-specific (general) indicator of liver disease.
27 Giuberti T, Marin MG, Marchelli S, Schianchi C, Degli Antoni AM, Pizzocolo G, Fiaccadori F. Hepatitis C virus viremai following
clinical resolution of acute hepatitis C. Journal of Hepatology 1994, 20: 666-671.
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Approximately 20% of those who developed chronic hepatitis had normal ALT on first follow-
up. The prognosis of hepatitis C infection is favourable in patients who have consistently
normal ALT. 
The final diagnostic groups are the mild and moderate/severe groups with chronic hepatitis C.
The term ‘moderate/severe’ is used to indicate that it is not possible to distinguish between
patients within this group on the basis of the data available. Only six patients, in the moderate
to severe groups, had severe disease on initial biopsy. One person had this confirmed by a
subsequent biopsy.
Pooling all of those with active disease (mild and moderate/severe), there was no discernable
change in disease status in the patient subgroup on whom biopsies were repeated (N=69). Nor
was it possible to identify any poor prognostic sub-group based on information available.
Routine biopsies at regular intervals would seem unnecessary, therefore, to monitor disease
activity. Patients with repeat biopsies tended to be those whose disease status might have given
greatest cause for concern. With this in mind, information available over the time period of
patient monitoring indicated no evident progression in the disease of those with repeat biopsies.
CURRENT PSYCHOLOGICAL WELL-BEING
Information from patient interviews on current evaluations of health and psychological well-
being and their association with service use and financial compensation was considered. Patient
views and experiences regarding stigma and confidentiality were also evaluated. The experience
of the group who were initially deemed negative for hepatitis C, but who were recalled for
testing in the past year (‘recall’ patients), is also outlined here. 
Over half of the group described their health as fair or poor, with little difference in patterns
across groups (Figure 6.1). Mood disorders of depression and anxiety were measured across
groups in the present review with a view to identifying need for counselling services. Those
participating in interviews completed the Hospital Anxiety and Depression Scale (HADS) 28. 
Proportions of patients with clinical levels of psychological distress were similar across patient
groups. Thirty-five percent of the group had anxiety scores of clinical concern with 26% having
clinical levels of depression (see Figures 6.2 and 6.3). 
These proportions indicate high levels of psychological distress in these patient groups. The
uncertain nature of hepatitis C consequences may account for the particularly high levels of
anxiety reported. HADS figures for the general population in Ireland and the UK are not
available for comparison. To provide some comparison, a German general population sample
______________________________
28 The HADS is a brief (14 questions) well-validated screening measure which indicates levels of depression and anxiety in the general
medical setting. This scale provides separate measures of depression and anxiety, each with scores in the ‘normal’, ‘borderline’ and
‘clinical’ range. Scores from 8 - 10 are ‘borderline’, serving to identify most possible cases of the relevant psychological problem with
score of 11+ are in the ‘clinical’ range meaning there is a high probability of problems needing professional mental health services.
Questions are asked about feelings ‘in the past week’. 
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had clinical levels of depression in 5% of the group with 7% at clinical anxiety levels29. A group
diagnosed with cardiological illnesses reported clinical depression (17%) and clinical anxiety
(19%) while back pain patients reported clinical depression (29%) and clinical anxiety (36%).
These figures provide some perspective on the group studied here and indicate that their levels
of psychological distress are high for a medical population.
There is evidence that counselling services were used significantly more by those with higher
levels of both depression and anxiety. For instance, 71% of those rated as clinically depressed
attended counselling, whereas rates of attendance for counselling for non-depressed individuals
was 27%. 
Very Good
Good
Fair
Poor
Figure 6.1: Current self-rated health by route of infection
______________________________
29 Hermann C. (1997) International experiences with the Hospital Anxiety and Depression Scale - a review of validation date and
clinical results. Journal of Psychosomatic Research, 1997; 42: 14-41 
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Figure 6.2: Patient anxiety score categories as measured by the HADS
Clinical depression
Borderline depression
Normal depression
Figure 6.3: Patient depression score categories as measured by the HADS
thirty eight
R
o
u
te
 o
f 
In
fe
ct
io
n
35
TOTAL          22
43
35
Transfusion 26
39
36
Haemophilia 16
48
36
Anti-D 18
46
0 10 20 30 40 50 60
%
R
o
u
te
 o
f 
In
fe
ct
io
n
26
TOTAL     13
61
29
Transfusion 18
53
24
Haemophilia 8
68
24
Anti-D 9
67
0 20 40 60 80 100
%
Compensation Tribunal attendance and psychological well-being
Sixty-three percent of those interviewed had attended the Compensation Tribunal by the time of
interview with no difference in attendance across groups. 
One issue which elicited very disparate views in discussion for the review was whether
psychological well-being is improved or disaproved following attendance at the Tribunal. On
the one hand, there was a view that there would be a great sense of relief for individuals post-
Tribunal, with a corresponding improvement in levels of psychological distress. The other
perspective was that the Tribunal is the focus of life for patients for a long time. When the
Tribunal is completed, patients would then find themselves with the rest of their lives and their
health uncertainty regarding hepatitis C to face. In this view, the post-Tribunal period would be
associated with greater distress for patients.
Data on psychological well-being from the HADS was evaluated by Tribunal status. The post-
Tribunal group were found to have a significantly more serious depression profile, with 32%
(versus 7% pre-Tribunal) scoring as clinically depressed30. There was a trend but no significant
differences in anxiety levels for those pre- and post-Tribunal31 (22% and 39% respectively).
Thus proportions of those scoring in the clinical level of depression were greater for those who
have already attended the Tribunal. While levels of anxiety were not statistically different across
groups, the actual level of anxiety displayed was high in both groups and therefore also cause
for concern.
DISCLOSURE, STIGMA, AND CONFIDENTIALITY
The stigma associated with hepatitis C was acknowledged by all groups (see Figure 6.4).
Associations of one’s hepatitis C with personal ill-health (for example, liver failure) and risk to
public health (infectivity) were seen as relevant alongside associations with inappropriate
personal behaviour (high alcohol use leading to liver disease), risky sexual conduct and illicit
and intravenous drug use (acquiring infectious diseases). The similarities in abbreviations of the
words human immunodeficiency virus (HIV) and hepatitis C virus (HCV) appears to have added
to a sense of stigmatisation with a small number of people reporting that they initially believed
they were infected with HIV.
Stigma is of particular concern because of its possible association with poor psychological well-
being and with inadvisable health practices which arise from feeling stigmatised (for example,
not seeking appropriate help; not disclosing one’s infection in a health setting). It is difficult to
quantify the latter. However, psychological well-being has been considered in relation to stigma
(see Figure 6.4). Feeling stigmatised was strongly associated with high levels of both depression32
and anxiety33.
______________________________
30 (χ2=7.71; df=2; p=0.02).
31 (χ2=5.29; df=2; p=0.07).
32 (χ2=27.9; df=6; p=0.0003).
33 (χ2=25.1; df=6; p=0.0003).
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Quite a lot/very much
None/very little
Figure 6.4: Levels of stigma experience as a result of having hepatitis C by route of
infection
One of the ways in which health or other problems can be seen as less stigmatising is by
increasing contact with individuals in a similar situation. When asked their views, most people
perceived direct personal contact with others to be unhelpful while support organisation contact
was considered helpful or very helpful by a majority. 
Disclosure of hepatitis C to others
Disclosure of conditions deemed stigmatising involves both a decision to tell others and the act
of disclosure itself. One person interviewed had told no-one to date about his hepatitis C. Some
had told just a few individuals while others reported that ‘everyone knows’. Confidentiality in
dealing with hepatitis C services is a key concern for both professionals and service users. Patient
satisfaction with confidentiality in various aspects of service provision is outlined in Figure 6.5.
Levels of satisfaction with confidentiality were uniformly high across health services from
hospital to community. These satisfaction ratings contrasted with lower reported levels of
satisfaction with confidentiality in employment settings. Given high feelings of stigmatisation
and related concerns, the achievement of this level of confidence across a range of health
systems, locations, and personnel is highly reassuring and to be commended.
R
o
u
te
 o
f 
In
fe
ct
io
n
forty
37
TOTAL     63
38
Transfusion 62
40
Haemophilia 60
41
Anti-D 59
0 20 40 60 80
%
Satisfied
Figure 6.5. Patient satisfaction with confidentiality regarding hepatitis C in various
health and related services
RECALL PATIENTS
A distinct group interviewed as part of this study were those who, having initially tested
negative for hepatitis C, were asked to return for further testing at a later date. Most of these
individuals had been called for re-testing within the previous year. Satisfaction ratings with
staff during retesting were adequate (74% satisfied) as were satisfaction ratings with
experience of the hepatology unit (74%).
Over half of those interviewed (52%) felt they did not have an adequate understanding of why
they were being retested at the time and 50% remain confused about the reason for re-testing.
A significant proportion of these individuals (48%) report still feeling fearful about the
diagnosis of hepatitis C. Regarding current status, self-rated health was similar to other groups
(poor 14%; fair 57%; good 29%; very good 0%). Recall group depression and anxiety scores
(as measured by the HADS) did not differ significantly from those of the interview population
as a whole. The scores of 14% of individuals indicated clinical levels of depression; the scores
of 29% of individuals indicated clinical levels of anxiety. Only one recall patient had been to
the Tribunal.
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OVERALL 86
Hepatology unit 90
General hospital 82
GP 99
Health board 82
Counselling 93
Home support 71
Other health board 85
Pharmacy 81
Employer 62
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FUTURE NEED FOR SECONDARY CARE SERVICES
The need for clinical services over and above those of an ageing population, some already with
chronic disease such as haemophilia, was seen as difficult to estimate by professionals. The view
was that only a minority of patients would ever develop serious, end-stage liver failure. Services
more likely to be in demand were seen to be those associated with general symptoms of fatigue
and rheumatoid difficulties. Hence rheumatology (including physiotherapy) services were
expected to be in increasing demand.
Anti-viral treatment
The main increase in demand for secondary care services in the short-term is expected to be in
the provision of anti-viral treatment for hepatitis C. Recent clinical trials indicating that
interferon and ribavarin as combination therapy are beneficial, and more effective than
interferon alone, will result in increased numbers availing of this treatment with associated
hospital stays, laboratory tests, and other clinical procedures and staff time associated with such
procedures. 
Liver transplantation
For those small numbers requiring liver transplantation, ongoing support for the National Liver
Transplant Centre at St Vincent’s Hospital, Dublin, was seen as important. Because of the needs
of this and other hepatitis C groups, an additional transplant surgeon specialising in infectious
hepatology was seen to be necessary. Support organisations felt strongly that liver
transplantation should be facilitated, including international travel for transplantation where
necessary. Others cautioned, however, that efforts to ensure an active programme of donation
to complement transplantation in this country are a more feasible focus for service provision
since the process of organ transplantation and recovery has sufficient challenges for patient and
family without the additional burden of travel and geographical separation from extended
family and friends.
FUTURE NEED FOR PRIMARY CARE SERVICES
The general view of professionals was that demand for counselling will increase in the next few
years. This was the majority view of consultants, nursing staff, GPs, health board liaison
officers, counsellors, and support organisations. Where increases are expected, they are seen to
relate to coping with increased illness over the lifetime and with undergoing interferon therapy.
General practitioner
There was strong endorsement of the importance of the primary care role (with GPs at the centre
of this and with practice nurses playing an important role) in the ongoing care of this group. 
Professionals expressed concern that general health promotion and screening activities relevant
to this group (such as hormone replacement therapy for the anti-D group), which are normally
conducted through general practice, could be relatively neglected where the person’s primary
medical contact was a hospital specialist. However, support groups were conscious of the need
for ongoing specialist contact; this was most evident in those groups who already had pre-
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existing medical conditions when exposed to hepatitis C infection. Here, a significant move to
redirect patient care from secondary to primary care would not be uniformly welcomed.
GPs were seen as having a role in identifying individuals at risk who have not come forward for
testing to date either through fear, or through lack of contact from Blood Transfusion Service
Board records. GPs are also clearly seen as having an important role in plans for the future
where additional patients will be recalled for testing. The Department of Health and Children’s
Expert Group has identified GPs as the first point of contact for this group and, in consultation
with the Irish College of General Practitioners, plan to provide GPs with educational material
so that they can make contact with relevant patients. A need was identified to develop and
regularly update a comprehensive national GP listing (as recommended in the Expert Group
Report, 1995) to facilitate this process. 
There was general agreement that the demand for the home support service will increase over
the next few years. No dramatic changes in other service lists were expected in the short term.
Use of home nursing services was expected to be a significant resource demand for a small
number of individuals in the longer term.
Management of public health crises
There was seen to be a need for national planning for public health crises such as the 1994
hepatitis C issue, so that a system can be established to guide management of future,
unpredictable but probably inevitable incidents. Expertise is available within the health and
associated services to develop a blueprint for such a system34. Those producing critical incident
strategies for hospitals, public health and public venue settings could combine to plan a generic
system. 
FUTURE CHALLENGES
Continuing challenges include making explicit best practice guidelines for biopsy and anti-viral
therapies such that patients are confident that individual treatment variation across centres is
part of a flexibility to suit patients in delivering what is otherwise a basically similar and high
quality service to all. Ensuring that access to additional specialist services is as outlined in the
‘two-week rule’, and managing home support services with safety and confidentiality were also
seen as continuing challenges. It was felt that the focus should be on ‘managed wellness’ rather
than on ‘patient’ or ‘illness’ status with health promotion advice becoming important for long-
term well-being, now that the initial challenges of diagnosis and assessment are completed. It
was also felt that specific health promotion guidance, including in particular advice about diet
and management of fatigue, should be developed and disseminated to this group of individuals
with hepatitis C.
______________________________
34 O’Riordan PA. Emergency planning in Ireland. Dublin: Institute of Public Administration, 1992.
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Apart from their health status, the major concern for the future, as expressed by both service
providers and users, was that funding would continue to be made available to this group in the
demand-led manner in which it was committed and is provided at present. Official reassurances
on this continue to be necessary in order to allay fears that at a future time, recall about
commitments following the 1994 contamination announcements will have faded and be
overtaken by budgetary or other considerations. It is difficult to overstate the level of this
concern and its pervasiveness across the individuals interviewed at every level of the system.
Means of acknowledging these fears and reaffirming the commitments made should be
considered to reassure those infected.
Recommendation 11: That assurances be given that adequate funding and
resources will continue to be provided to ensure a quality health care service for
this patient group.
Input to this Review was broad-ranging, with representation from patient support
organisations, patients and professionals. Recommendations provided throughout the report are
based on the evidence collected from these different sources. Implementation of these
recommendations should serve to underpin quality patient care into the future.
Recommendation 12: That progress on the recommendations of this Review be
monitored on an annual basis for three years with a report summarising
progress to be completed at the end of this period. Progress to be monitored by
a sub-committee of the Consultative Council on Hepatitis C.
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Chapter 7
CONCLUSIONS 
The hepatitis C contamination of blood products on the scale announced in Ireland in 1994 was
unique both in the Irish and international setting. The wide distribution of a very large number
of mostly women (because the intermediary for infection was anti-D immunoglobulin) meant
that the impact of the contamination was experienced by individuals, families, and professionals
throughout the country. The anger and hurt felt at the time appears to have resolved
considerably. As summarised in previous chapters, it appears that the constituents necessary for
effective service delivery are broadly in place and that both specialist units and primary care
services are working to agreed standards. 
Challenges for the future
A new level of negotiation of service use has been brokered by the nature in which the hepatitis
C contamination issue arose and was managed over time. The development of good working
relationships by groups with the Department of Health and Children over time was also
acknowledged, with current relationships seen as having evolved from an initially adversarial
stance, to a partnership approach with the liaison personnel at present.
Principles and standards
A level of mutual trust appears to have been established between professionals and service users.
The major concern of all concerned is to maintain this equilibrium and the resources associated
with it in the future. This summary appraisal is not to say that problems do not continue to
emerge in the delivery of care. These problems focus mainly on communication – between
professionals and service users, and among professionals. However, a level of acceptance that
these problems need to continue to be resolved in this setting is more reflective of a partnership
approach than is probably available elsewhere within the health delivery system. In itself, this
reflects a significant move forward in the relationship between providers and users of care that
is aspired to more generally; for instance, in the Department of Health’s 1994 health strategy
document which seeks to foster a more consumer-oriented approach to health service delivery.
In conclusion, the hepatitis C issue has proved to be one of the major challenges to face our
current health services. We hope that this Review, as part of a broader strategic approach to
managing hepatitis C, will ensure optimal management into the future.
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APPENDICES
Appendix 1: Consultation process for hepatitis C services review: those
interviewed/consulted for review 
Organisation Personnel 
HOSPITALS
Beaumont Hospital, Dublin  Dr Frank Murray, Consultant Gastroenterologist
 S/N Marie Wilson
 Ms Sinead Purcell, Secretary
Cork University Hospital  Dr Elizabeth Kenny, Locum Consultant
Gastroenterologist
 Dr Michael Whelton, Consultant Gastroenterologist
 Sr Susan Corbett
 Ms Nora O’Connor, Secretary
 Mr Tony McNamara, Hospital Manager
 Mr Michael Crowley, Statistician
 Ms Claire Devereaux, Statistical Support
Mater Hospital, Dublin  Dr John Crowe, Consultant Gastroenterologist
 Sr Alice Cockram
 Ms Margaret McAndrews, Secretary
 Ms Barbara Coughlan, Counsellor
St James’s Hospital, Dublin  Professor Dermot Kelleher, Consultant
Gastroenterologist
 Sr Helena Irish
 S/N Breda Jordan (Job-sharing) 
 Ms Sylvia Mathews, Secretary
St Luke’s Hospital, Kilkenny  Dr Gary Courtney, Consultant Physician and
Gastroenterologist
 Sr Catherine Whitely
 Sr Pauline Carroll
 Ms Ann Marie McDonald, Secretary
St Vincent’s Hospital, Dublin  Dr. John Hegarty, Consultant Gastroenterologist
 Sr (acting) Deirdre O’Sullivan
 Ms Sarah Lynch, Secretary
University College Hospital, Galway  Professor Ciaran McCarthy, professor of Medicine
and Consultant Gastroenterologist
 Dr John McWeeney, Locum Consultant Physician
 S/N Mary Keane-Bowhan, Locum Clinic Nurse
 Ms Sheena Laverty, Secretary (Part-time)
HEALTH BOARDS: HEPATITIS C LIAISON OFFICERS
Eastern Health Board (Dublin)  Ms Sheila Marshall, Hepatitis C Liaison Officer,
Community Care
Midland Health Board (Tullamore)  Mr Pat O’Dowd, Administrator, GP Unit
Mid-Western Health Board (Limerick)  Ms. Mary Healy, Senior Executive Officer,
Community Care
North Eastern Health Board (Dundalk)  Ms Ann Coyle, Senior Executive officer, Community
Care
 Ms Rosemary Mulligan, Secretary to Ms Coyle
North Western Health Board  Mrs Val O’Kelly,
(Manorhamilton) Acting Child Care Development Officer
South-Eastern Health Board (Kilkenny)  Ms. Anne Marie Lanigan, GP Unit Manager
Southern Health Board (Cork)  Ms Cathy Falvey (Newly Appointed)
 Mr Donal Murphy (Outgoing)
Western Health Board  Mr Matt Hurley (Newly Appointed)
 Mr Brian O’Donnell (Outgoing)
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(Continued on next page)
Appendix 1: continued
Organisation Personnel
PRIMARY CARE
Irish College of General Practitioners (ICGP)  Dr Michael Dunne (Cork)
 Dr Michael Coughlan (Galway)
 [ICGP designated specialists re. Hepatitis C]
Counsellors  Ms Pauline Beegan (Positive Action; Irish Kidney
Association)
 Ms Jo Campion (Independent Practice)
 Ms Anne Ryan (Beaumont Hospital)
 Ms Siobhan Sciascia 
(University College Hospital Galway)
SUPPORT GROUPS
Irish Haemophilia Society  Ms Margaret King, Counsellor
 Ms Rosemary Daly, Administrator
Irish Kidney Association  Mrs Patricia Doherty, Chief Executive
Positive Action  Ms Jane O’Brien, Chairperson
 Ms Mary O’Connor, CEO, and Committee Member
 Ms Pauline Beegan, Psychologist (also works for Irish
Kidney Association)
Transfusion Positive  Ms Maura Long, Chairperson & Committee Member
Support group members nominated by  28 individuals divided across four focus groups – one
groups and invited to take part in two for each infection route – names not published to
hour focus group in Dublin protect confidentiality
INDIVIDUAL INTERVIEWS WITH PERSONS INFECTED WITH HEPATITIS C
 132 interviews of between one and two hour
duration
-  115 face-to-face interviews (87%)
-  17 telephone interviews (13%)
RELEVANT NATIONAL AGENCIES
Blood Transfusion Services Board  Mr Martin Hynes, Chief Executive
 Dr Emer Lawlor, Consultant Haematologist
Department of Health and Children  Dr Jim Kiely, Chief Medical Officer and Chairman of
Expert Group on hepatitis C
 Ms Mary Hogan and Mr Gerry Coffey, Blood Policy
Division
Health Research Board  Dr Ruth Barrington, Chief Executive Officer
 Ms Carol Cronin, Accountant
OTHER SOURCES OF EXPERTISE
Beaumont Hospital  Dr Elaine Kay, Consultant Pathologist and Senior
Lecturer, Department of Pathology (RCSI)
Royal College of Surgeons in Ireland (RCSI)  Mr Ronan Conroy, biostatistician, Department of
Epidemiology and Public Health Medicine
 Professor William Shannon, Department of General
Practice
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Appendix 2(A): Hepatitis C research projects funded by the Health Research Board (1996-1998 grant
awards) and other major research funding agencies
Grant holders/ Project
Total Additional
institutions duration
funding* funded
Title £ personnel
Chronic HCV Infection: Clearance L Fanning, J Collins, F 1996-1999 33,000
and persistence – Shanahan (Cork 
the underlying mechanisms University Hospital)
Extrahepatic reservoirs of HCV L Fanning, J Collins, 
F Shanahan 1996-1999 47,000 postgraduate 
student
Human reproduction and hepatitis C M Whelton 
(Cork University Hospital) 1997-2000 44,620 MSc. research 
The role of human leucocyte antigens E Lawlor, J. Power, 1997-1998 25,000 assistant
in the persistence of hepatitis D Kelleher 
C infection (BTSB St James’s 
Hospital Dublin)
To correlate HLA-DR allele status J Crowe 1997-2000 35,450 postdoctoral 
with outcome in women with proven (Mater Hospital Dublin) fellow
exposure to HCV contaminated
anti-D innumoglobulin in 1977
An investigation of the pathogenesis E Kay, M Leader, 1997-1999 57,582 postgraduate 
and severity of chronic disease in C O’Keane student,
anti-D treated patients with hepatitis (Beaumont Hospital medical
C virus Dublin and RCSI) laboratory
technician
Groups infected or tested as at risk A Hickey, C O’Boyle 1997-2000 42,674 Research nurse
for the hepatitis C virus in Ireland: (Royal College of Surgeons
psychological functioning and lessons in Ireland)
for communications of health risk
information in the future
Detection of intrahepatic hepatitis S Barrett, J Crowe 1997-1998 8,500
C viral RNA in RIBA positive, PCR (Mater Hospital Dublin)
negative anti-D recipients
Virus variants and host immune J Hegarty 1997-2002 741,972 two senior 
responses in the resolution and (St Vincent’s Hospital), postdoctoral 
progression of chronic liver disease D Kelleher (St James’s fellows; two
following hepatitis C virus infection Hospital), K Mills (NUI postdoctoral
Maynooth), B Hall (Virus fellows
Reference Laboratory)
An exploration of the psychological J Crowe, J Sheehan, 1998-2000 36,000 postgraduate
impact of an accidental diagnosis B Coughlan researcher
of hepatitis C infection on a (Mater Hospital Dublin)
previously healthy female population
Correlation of HLA-DR status with J Crowe, E Ryan 1996-1998 20,000
outcome in women with proven (Mater Hospital Dublin)
exposure to hepatitis C virus
contaminated anti-D
immunoglobulin in 1977
Pathogenesis of hepatitis C D Kelleher 1998-2000 70,000 postdoctoral
(St James’s Hospital), (pharmaceu- fellow
C Ferran (Pharma) tical company
funds)
Biomedical effects of interferon D Kelleher 1997-1999 50,000 medical fellow
(EU funds) (St James’s Hospital)
* HRB-funded unless otherwise indicated
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Appendix 2(B): Hepatitis C research projects conducted by or for health services
organisations or support organisations
Study details Funding source Contact
Cork University Hospital (CUH) Joint project between Dr Elizabeth Kenny
 Hepatitis C comprehensive database CUH and Department (locum consultant
template development from 1995 of Statistics, University gastroenterologist) and
to collect wide range of clinically College Cork. Professor Fergus Shanahan
relevant data as part of routine (professor of medicine,
practice (16 separate sections) Cork University Hospital)
Purpose – to optimise clinical 
management, healthcare planning, 
and research into future progression 
of hepatitis C in an iatrogenically-
induced group; to adopt this as 
national database
Eastern Health Board (EHB) Completed by EHB’s Ms Sheila Marshall
 Postal survey of satisfaction with Department of Public (liaison officer)
community services (N=467 covered Health (Dr Emer Feeley
by scheme; 56% response) – co-ordinator)
Purpose – internal review to inform
board operations
Positive Action
 Postal survey of PA members in Work facilitated by Drs Ethel Quayle and
1995 to assess psychological wellbeing. Positive Action and Elizabeth Dunne 
N=600 with 38% response rate funded by University (psychologists, Department
Purpose – baseline psychosocial College Cork of Applied Psychology, UCC)
information for PA 
 1999 postal survey of c. 700 Funded by Positive Action Ms Pauline Beegan,
members on appointment of (psychologist, Positive 
Positive Action psychologist. Action)
N=170 replies (c. 24% response rate) 
Purpose – to ascertain counselling 
priorities and preferences of group
 Quantitive study: 6 focus groups Funded by Positive Action Drs Ethel Quayle and
(N=45) of PA members representing and completed at Elizabeth Dunne 
urban/rural members University College Cork (psychologists, Department
Purpose – evaluation of impact on of Psychology, UCC)
everyday life
St Luke’s Hospital, Kilkenny South Eastern Health Ms Pauline Carroll 
 A nursing-focused review of Board and individual (staff nurse) and
pathological, psychological, and registration for Batchelor Dr Gary Courtney 
social aspects of anti-D associated of Nursing Studies (consultant physician)
hepatitis C Courses, TCD
Purpose – to develop evidence-based 
nursing care strategies
University College Hospital, Galway
 Two surveys of patient satisfaction Completed by Western Professor Ciaran McCarthy
with services Health Board (professor of medicine,
Purpose – internal reports to ascertain University College Hospital
level of patient concerns re. services Galway)
(survey 1) and to re-evaluate views 
following service changes (survey 2)
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Fifty
